
CenterWell is the healthcare delivery brand of Humana Inc. (NYSE: HUM), launched in 2022 to unify the company's primary care, home health, and pharmacy services. CenterWell Senior Primary Care grew more than 25 percent in 2025, adding over 100,600 patients including roughly 32,000 from The Villages Health acquisition, and plans 60 to 70 new clinics and 120,000 to 140,000 new patients in 2026. CenterWell Home Health, built from the Kindred at Home acquisition, is the largest home health provider in the United States.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| CenterWell | Humana Inc. | Wholly owned |
Humana assembled its care-delivery platform through acquisitions and organic growth: its senior primary care business (formerly Partners in Primary Care), the Kindred at Home acquisition (which made Humana the largest US home health provider, completed in stages in 2021 and 2022 for roughly $8.1 billion enterprise value), its pharmacy operations (formerly Humana Pharmacy), and the Conviva senior care brand in Florida and Texas.
In 2022, Humana rebranded the collection as CenterWell, positioning it as an integrated healthcare delivery platform rather than a collection of insurance-support services. The strategy treats primary care, home health, and pharmacy as the operational core of Humana's value-based care model: patients cared for in CenterWell clinics have better outcomes and lower total cost of care, improving Medicare Advantage margins when those patients are Humana members.
Growth accelerated in 2025 and 2026: CenterWell Senior Primary Care added more than 100,600 patients in 2025, The Villages Health acquisition contributed roughly 32,000 patients in Florida, and the MaxHealth acquisition closed in Q1 2026. Humana guided to 60 to 70 new clinics and 120,000 to 140,000 additional patients in 2026, with management expecting CenterWell to drive increasing earnings contribution as the business matures.
What does Humana own?
Humana owns a portfolio of health insurance and healthcare service brands organized under the Humana master brand and the CenterWell service brand. The portfolio includes Humana Medicare (Medicare Advantage plans), Humana Medicaid (managed care in 13 states), Humana Marketplace (ACA exchange plans), Humana Pharmacy (prescription drug services), CenterWell (senior primary care clinics, pharmacy, and home health), Humana Group Plans (employer-sponsored specialty products), and Humana Individual Plans (individual and family coverage).
Is Humana publicly traded?
Yes. Humana Inc. trades on the New York Stock Exchange under ticker symbol HUM. The company has been publicly traded since its corporate restructuring in the 1990s and is a component of major healthcare sector indices. Its market capitalization fluctuates with earnings performance and Medicare Advantage policy developments.
Who founded Humana?
Humana was founded in 1961 by David A. Jones Sr. and Wendell Cherry in Louisville, Kentucky, originally as a nursing home company called Extendicare Inc. The company pivoted to hospital management in the 1970s and then to health insurance in 1993, when it spun off its hospital operations. Jones served as CEO for decades and remained chairman until his retirement.
Where is Humana headquartered?
Humana is headquartered in Louisville, Kentucky, USA. The company has maintained its headquarters in Louisville since its founding in 1961. Humana operates major offices and care delivery facilities across the United States to support its national Medicare Advantage and Medicaid operations.
How many brands does Humana own?
Humana owns 8 major brands and product lines across its health insurance and healthcare services portfolio. These include Humana Medicare, Humana Medicaid, Humana Marketplace, Humana Pharmacy, Humana Healthcare Services, CenterWell, Humana Group Plans, and Humana Individual Plans. The company uses a focused brand strategy rather than a broad multi-brand portfolio.
Who owns Humana?
Humana is publicly owned with shares trading on the NYSE under ticker HUM. Ownership is distributed among institutional investors, mutual funds, and individual shareholders. No single shareholder holds a controlling interest. Major institutional holders include Vanguard Group, BlackRock, and State Street Corporation. The company operates independently without any parent organization.
What is Humana's revenue?
Humana reported FY2025 revenue of $129.7 billion, up from $117.8 billion in FY2024. For FY2026, the company guided to total revenue of at least $160 billion. The Insurance segment generated $124.6 billion in FY2025 revenue, representing 96.3% of consolidated premiums and services revenue. The company's revenue is heavily concentrated in Medicare Advantage, which accounted for 82.6% of Insurance segment premiums in FY2025.
Is Humana involved in any legal proceedings?
Yes. Humana is appealing a federal court's October 2025 decision rejecting its challenge to CMS Star Ratings methodology. The company also faces an ongoing DOJ investigation into Medicare Advantage risk adjustment practices. Additionally, Humana is subject to routine litigation related to claim denials and coverage decisions, which is typical for large health insurers. The company discloses material legal matters in its SEC filings.
CenterWell's model is built on access for seniors, dual-eligible patients, and underserved populations, embedding social-determinants screening, transportation support, and preventive care. The value-based payment structure incentivizes keeping patients healthy rather than volume, aligning clinical and ethical goals.
CenterWell's value-based primary care model has been recognized in industry assessments of Medicare Advantage outcomes, and its clinics carry NCQA-aligned quality programs. The home health business holds leading market-share recognition in post-acute care rankings.
Integration Complexity: Consolidating Kindred at Home's home health operations, Partners in Primary Care clinics, and pharmacy systems under a single brand required multi-year integration with periodic service disruptions.
Value-Based Care Dependence: The model's economics are tied to Medicare Advantage risk adjustment and CMS reimbursement, subjecting clinical operations to the same policy pressures as the insurance business.
Acquisition Costs: The Kindred at Home and subsequent clinic acquisitions required substantial capital, and the payback depends on scaling patient volume while maintaining quality metrics.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Humana | USA | 2022 | Growth segment | United states | Seniors-65-plus | |
| Cvs Health | USA | 2012 | Mass market | United states | All Genders | |
| Cvs Health | USA | 1963 | Mass market | United states | All Genders | |
| Unitedhealth Group | United States | 2011 | Mass market | United states | All Genders | |
| Humana | USA | 2000 | Integrated | United states | All-ages |
Healthcare PharmaceuticalsOwned by Humana Inc.
Humana's healthcare delivery division, now operating as the CenterWell segment, combining senior primary care, home health, pharmacy, and related care services.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American network of value-based primary care centers for Medicare patients, founded in 2012 and acquired by CVS Health in 2023 for $10.6 billion. Operates about 230 centers across 27 states.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American pharmacy retail chain and one of the largest pharmacy networks in the United States, owned by CVS Health.
Healthcare PharmaceuticalsOwned by UnitedHealth Group
UnitedHealth Group's healthcare delivery and value-based care division employing or affiliating with more than 90,000 physicians, generating $105.4 billion in 2024 revenue as one of the largest physician employers in the United States.
Healthcare PharmaceuticalsOwned by Humana Inc.
Humana's mail-order and specialty pharmacy business, rebranded CenterWell Pharmacy in 2022 and serving millions of Humana members with home delivery and specialty drug services.
Market Positioning: CenterWell competes with 5 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Humana Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike CenterWell which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Duane Reade is privately owned, unlike CenterWell which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike CenterWell which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike CenterWell which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike CenterWell which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
Amgen operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.